Earnings Feed
Start Free
Home/Filings/4/0001638599-16-001125
4//SEC Filing

CorMedix Inc. 4

Accession 0001638599-16-001125

$CRMDCIK 0001410098operating
View on SEC.govCompany Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 4:30 PM ET

Size

30.5 KB

Accession

0001638599-16-001125

Insider Transaction Report

Form 4
Period: 2016-06-20
CorMedix Inc.CRMD
Pfaffle Antony
Director
Transactions
  • Sale

    Common Stock, $0.001 par value per share

    2016-06-20$2.17/sh−5,000$10,857→ 5,000 total
  • Sale

    Common Stock, $0.001 par value per share

    2016-06-20$2.14/sh−5,000$10,712→ 0 total
  • Sale

    Common Stock, $0.001 par value per share

    2016-06-21$2.15/sh−2,000$4,306→ 819 total
  • Exercise/Conversion

    Common Stock, $0.001 par value per share

    2016-06-21$0.68/sh+19,657$13,367→ 19,657 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2016-06-21+19,657→ 100,000 total
    Exercise: $0.68Exp: 2022-12-05→ Common Stock, $0.001 par value per share (19,657 underlying)
  • Sale

    Common Stock, $0.001 par value per share

    2016-06-21$2.21/sh−819$1,812→ 0 total
  • Sale

    Common Stock, $0.001 par value per share

    2016-06-21$2.12/sh−9,657$20,481→ 10,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2016-06-20+10,000→ 119,657 total
    Exercise: $0.68Exp: 2022-12-05→ Common Stock, $0.001 par value per share (10,000 underlying)
  • Exercise/Conversion

    Common Stock, $0.001 par value per share

    2016-06-20$0.68/sh+10,000$6,800→ 10,000 total
  • Sale

    Common Stock, $0.001 par value per share

    2016-06-21$2.11/sh−7,181$15,173→ 2,819 total
Holdings

  • Stock Option (right to buy)

    Exercise: $2.02Exp: 2024-01-09→ Common Stock, $0.001 par value per share (100,000 underlying)
    100,000

  • Stock Option (right to buy)

    Exercise: $2.10Exp: 2021-01-14→ Common Stock, $0.001 par value per share (30,000 underlying)
    30,000

  • Stock Option (right to buy)

    Exercise: $5.00Exp: 2025-02-24→ Common Stock, $0.001 par value per share (75,000 underlying)
    75,000

  • Stock Option (right to buy)

    Exercise: $2.27Exp: 2024-04-01→ Common Stock, $0.001 par value per share (100,000 underlying)
    100,000

  • Stock Option (right to buy)

    Exercise: $2.02Exp: 2024-01-09→ Common Stock, $0.001 par value per share (30,000 underlying)
    30,000

  • Stock Option (right to buy)

    Exercise: $0.90Exp: 2023-03-22→ Common Stock, $0.001 par value per share (210,000 underlying)
    210,000

  • Stock Option (right to buy)

    Exercise: $3.13Exp: 2020-03-30→ Common Stock, $0.001 par value per share (20,000 underlying)
    20,000
Footnotes (14)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.16 to $2.19, inclusive.
  • [F10]These options vest based on performance milestones running through December 31, 2014.
  • [F11]These options vested as follows: (a) fifty percent (50%) on the date of the issuance of the CE mark certification, which occurred on July 5th, 2013, and (b) fifty percent (50%) on December 31, 2013.
  • [F12]These options vested on January 14, 2012.
  • [F13]These options vested as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.
  • [F14]These options were granted on February 24, 2015, and vested immediately.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.13 to $2.19, inclusive.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.11 to $2.13, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.13, inclusive.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.15 to $2.17, inclusive.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20 to $2.22, inclusive.
  • [F7]The options vested 100% on April 2, 2014.
  • [F8]The options vested 100% on January 10, 2014.
  • [F9]The options vest in full on the first anniversary of the date of grant.

Documents

1 file

Issuer

CorMedix Inc.

CIK 0001410098

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001410098

Filing Metadata

Form type
4
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:30 PM ET
Size
30.5 KB
View on SEC.gov